Skip to content
Press Releases
Filter Releases
EMERYVILLE, Calif., May 09, 2017 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today reported recent achievements and financial results for the first quarter ended March 31, 2017. "In the first quarter, we continued preparing for the potential approval and commercialization of ADS-5102, which, if approved, will be the first ...